Heterogeneous expression of E-cadherin and p53 in prostate cancer: Clinical implications

Emiel Ruijter, Christina Van De Kaa, Tilly Aalders, Dirk Ruiter, Gary Miller, Frans Debruyne, Jack Schalken, F. H. Schröder, C. G.M. Beeker, B. G. Blijenberg, A. E. Boeken Kruger, I. Eman, R. F. Hoedemaeker, W. J. Kirkels, R. Kranse, Th H. Van Der Kwast, M. A. Noordzij, H. J.A. Van De Poel, J. C. Romijn, G. J. Van SteenbruggeJ. Trapman, N. S. Verkaik, M. J.G. Bussemakers, D. Hessels, G. O.N. Oosterhof, T. E.G. Ruijter, J. A. Schalken, C. M.G. Thomas, J. A. Witjes, A. Ylikoski, T. Lövgren, J. Lövgren, K. Pettersson, T. Piironen, S. Mansikka-Savolainen, G. Ahlgren, C. Beeker, A. Bjartell, T. Björk, H. Lilja, A. Lundwall, P. A. Abrahamsson, O. Bratt, S. Colleen, P. Elfring, H. Frederiksen, S. Mårtensson, F. C. Hamdy, H. Y. Leung, D. E. Neal, C. N. Robson

Research output: Contribution to journalArticlepeer-review

47 Scopus citations

Fingerprint

Dive into the research topics of 'Heterogeneous expression of E-cadherin and p53 in prostate cancer: Clinical implications'. Together they form a unique fingerprint.

Medicine and Dentistry

Immunology and Microbiology

Pharmacology, Toxicology and Pharmaceutical Science

Veterinary Science and Veterinary Medicine

Keyphrases